10x Genomics, Inc. · NASDAQ:TXG
Suliman Shehnaaz sold 5,723 10x Genomics, Inc. shares (Form 4)
Traded Sep 22, 2026 · Filed Sep 24, 2026
On Sep 22, 2026, Suliman Shehnaaz (Director) sold 5,723 10x Genomics, Inc. shares at an average US$81.19 for US$465K under a trading plan, leaving 23,792 shares. Filed Sep 24, 2026 (Form 4).
- Sold
- 5,723 shares
- Price
- US$81.19 average (US$78.20 to US$82.28)
- Value
- US$465K
- Holding after
- 23,792 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Class A Common Stock | Sale | 292 | US$78.20 | 29,223 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 614 | US$79.51 | 28,609 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 1,325 | US$80.82 | 27,284 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 2,270 | US$81.67 | 25,014 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 1,222 | US$82.28 | 23,792 | Direct |
Source
Related
- 10x Genomics, Inc.
- Suliman Shehnaaz
- 10x Genomics, Inc. shareholders
- Form 4 · Suliman Shehnaaz · Aug 26, 2026
- Form 4 · Suliman Shehnaaz · Jun 18, 2026
- Form 4 · Suliman Shehnaaz · Jun 8, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026